What is sarcopenia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is Sarcopenia

Sarcopenia is a progressive skeletal muscle disorder characterized by loss of muscle mass, strength, and physical function, leading to increased risk of falls, disability, and death 1.

Core Definition

Sarcopenia represents a syndrome involving the generalized and progressive deterioration of skeletal muscle across three key dimensions 1:

  • Muscle mass: Quantitative loss of skeletal muscle tissue
  • Muscle strength: Reduced force-generating capacity
  • Physical performance/function: Impaired ability to perform daily activities

The condition primarily affects older adults as part of the aging process (primary sarcopenia), but can also develop secondary to disease, physical inactivity, or inadequate nutrition (secondary sarcopenia) 1.

Clinical Significance

The importance of recognizing sarcopenia lies in its association with serious adverse outcomes 2, 3:

  • Impaired mobility and increased fall risk
  • Higher morbidity and mortality rates
  • Reduced quality of life
  • Increased hospitalization and healthcare costs
  • Greater risk of osteoporotic fractures when combined with low bone density

Diagnostic Approach

The ESPEN-endorsed European Working Group on Sarcopenia in Older Persons provides the algorithmic framework for diagnosis 1:

Muscle Mass Assessment

Use validated measurement techniques:

  • DXA (Dual X-ray Absorptiometry): Appendicular skeletal muscle mass index <7.26 kg/m² (men) or <5.5 kg/m² (women)
  • BIA (Bioelectric Impedance Analysis)
  • CT scanning

Muscle Strength Assessment

Handgrip strength with cut-offs:

  • <30 kg for men
  • <20 kg for women

Physical Performance Assessment

Gait speed testing:

  • <0.8 m/s (or <1.0 m/s by some criteria)
  • Chair stand test for lower extremity function

Important Clinical Context

A critical pitfall is sarcopenic obesity, where muscle loss occurs while fat mass is preserved or increased 4. These patients may have normal body weight but marked weakness, making the condition easy to miss without specific assessment.

The definition has evolved significantly over recent decades—originally focused solely on muscle mass, current consensus emphasizes functional measures (strength and performance) as the primary diagnostic features 2, reflecting what matters most for patient outcomes.

References

Research

Clinical definition of sarcopenia.

Clinical cases in mineral and bone metabolism : the official journal of the Italian Society of Osteoporosis, Mineral Metabolism, and Skeletal Diseases, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.